Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 35 (35) 3949-55
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
7
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
Breast    Health Outcomes    
Pharmas:
 
Grants:
UG1CA189823, U10CA180790, U10CA180838, UG1CA189819  
Corr. Author:
 
Authors:
                 
Networks:
CHRISTIANA, LAPS-MN026, LAPS-NC007, NY021   
Study
CALGB-70604
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: